Sodexo - Disclosure of transactions in own shares carried out from April 28 to April 29, 2025 Regulated Information Issy-les-Moulineaux, May 2, 2025 DISCLOSURE OF TRANSACTIONS IN OWN SHARES CARRIED OUT FROM APRIL 28 TO APRIL 29, 2025 Sodexo purchased treasury shares, outside of its liquidity contract, within the framework of its share buyback program as authorized by the Shareholders’ Meeting held on December 17, 2024. These shares have been acquired to honor obligations related to free shares award plans. Information on these transactions are the following: Trading dateLEIISINVolume(i...
Sodexo - Déclaration des transactions sur actions propres réalisées du 28 au 29 avril 2025 Information réglementée Issy-les-Moulineaux, 2 mai 2025 DECLARATION DES TRANSACTIONS SUR ACTIONS PROPRES REALISEES DU 28 AU 29 AVRIL 2025 Sodexo a procédé à l’acquisition d’actions propres, hors contrat de liquidité, dans le cadre du programme de rachat d’actions autorisé par son Assemblée Générale du 17 décembre 2024. Ces acquisitions sont destinées à honorer des obligations liées à des plans d’attribution gratuite d’actions. Les informations agrégées sur ces opérations sont les suivantes : Jour ...
A director at Pernod-Ricard bought 315 shares at 95.200EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Lung Cancer Cough (LCC) is an under-served, perhaps unserved therapeutic subsegment of the Lung Cancer/Oncology market. 57-65% of early diagnosis lung cancer patients suffer from LCC, it is a highly debilitating condition. The US lung cancer therapeutics market consensus values range from ~USD 29.9bn in 2023 to ~USD 71.3bn in 2034, suggesting a compound annual growth rate (CAGR) of 8.2% over our 10 year forecast period. LCC is a prevalent symptom among lung cancer patients, and its management is...
Sodexo - Disclosure of transactions in own shares carried out from April, 22 to April, 24, 2025 Regulated Information Issy-les-Moulineaux, April 28, 2025 DISCLOSURE OF TRANSACTIONS IN OWN SHARES CARRIED OUT FROM APRIL 22 TO APRIL 24, 2025 Sodexo purchased treasury shares, outside of its liquidity contract, within the framework of its share buyback program as authorized by the Shareholders’ Meeting held on December 17, 2024. These shares have been acquired to honor obligations related to free shares award plans. Information on these transactions are the following: Trading dateLEIISINVol...
Sodexo - Déclaration des transactions sur actions propres réalisées du 22 au 24 avril 2025 Information réglementée Issy-les-Moulineaux, 28 avril 2025 DECLARATION DES TRANSACTIONS SUR ACTIONS PROPRES REALISEES DU 22 AU 24 AVRIL 2025 Sodexo a procédé à l’acquisition d’actions propres, hors contrat de liquidité, dans le cadre du programme de rachat d’actions autorisé par son Assemblée Générale du 17 décembre 2024. Ces acquisitions sont destinées à honorer des obligations liées à des plans d’attribution gratuite d’actions. Les informations agrégées sur ces opérations sont les suivantes : Jo...
A director at Sodexo bought 9,030 shares at 55.495EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.